Correlation Between Summit Therapeutics and Semper Paratus

Can any of the company-specific risk be diversified away by investing in both Summit Therapeutics and Semper Paratus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Summit Therapeutics and Semper Paratus into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Summit Therapeutics PLC and Semper Paratus Acquisition, you can compare the effects of market volatilities on Summit Therapeutics and Semper Paratus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Summit Therapeutics with a short position of Semper Paratus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Summit Therapeutics and Semper Paratus.

Diversification Opportunities for Summit Therapeutics and Semper Paratus

0.0

Correlation Coefficient

Summit Therapeutics  Semper Paratus

Pay attention - limited upside

The 3 months correlation between Summit and Semper is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Summit Therapeutics PLC and Semper Paratus Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Semper Paratus Acqui and Summit Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Summit Therapeutics PLC are associated (or correlated) with Semper Paratus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Semper Paratus Acqui has no effect on the direction of Summit Therapeutics i.e., Summit Therapeutics and Semper Paratus go up and down completely randomly.

Pair Corralation between Summit Therapeutics and Semper Paratus

If you would invest  1,787  in Summit Therapeutics PLC on December 20, 2024 and sell it today you would earn a total of  224.00  from holding Summit Therapeutics PLC or generate 12.53% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Summit Therapeutics PLC  vs.  Semper Paratus Acquisition

Summit Therapeutics PLC

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Summit Therapeutics PLC are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak primary indicators, Summit Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Semper Paratus Acqui

Risk-Adjusted Performance

Very Weak

Over the last 90 days Semper Paratus Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Semper Paratus is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Summit Therapeutics and Semper Paratus

The main advantage of trading using opposite Summit Therapeutics and Semper Paratus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Summit Therapeutics position performs unexpectedly, Semper Paratus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Semper Paratus will offset losses from the drop in Semper Paratus' long position.

The idea behind Summit Therapeutics PLC and Semper Paratus Acquisition pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.